Inventor
NICHOLAS J. PAPADOPOULOS
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
C12NMicroorganisms or enzymes5%
Y02ATechnologies for adaptation to climate change5%
PatentTitleYear
12,162,943High affinity human antibodies to human IL-4 receptor202412,037,388Anti-IL-33 antibodies and uses thereof202411,820,815Human antibodies to human delta like ligand 4202311,578,135Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof202311,370,843High affinity antibodies to human IL-6 receptor202211,155,621Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to REGENERON PHARMA (6)· patent assignee history
2021Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
2021–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 6 | 2021–2024 |
| REGENERAN PHARMACEUTICALS INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2024 |